Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis (Q59616825)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 2006

Language	Label	Description	Also known as
English	Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis	scientific article published on 01 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

0 references

Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Walter Jonat

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Francesco Boccardo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Manfred Kaufmann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Alessandra Rubagotti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Ivan Zuna

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Mike Greenwood

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Raimund Jakesz

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

991-996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary Results From the Cancer Research Campaign Trial Evaluating Tamoxifen Duration in Women Aged Fifty Years or Older With Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen resistance in breast cancer: elucidating mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of third-generation aromatase inhibitors on bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular safety profiles of aromatase inhibitors : a comparative review.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of anastrozole in adjuvant therapy for postmenopausal patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970948-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(06)70948-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17138220%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q59616825&oldid=1962209934"